Skip to content

Archive

A five-year international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment taken twice daily to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2.

University of Washington researchers have discovered a way to more accurately predict life expectancy in patients newly diagnosed with Glioblastoma Multiforme, the most aggressive form of primary brain tumors — and the type that took the life of Senator Ted Kennedy earlier this year.